Connect with us

Tech

‘Elon Musk’s Neuralink may have illegally transported pathogens’

Published

on

'Elon Musk's Neuralink may have illegally transported pathogens'

An animal-welfare organization said it plans to ask a U.S. government agency on Thursday to investigate Elon Musk’s brain-implant company Neuralink over records it said show potentially illegal movement of hazardous pathogens.

The Physicians Committee of Responsible Medicine (PCRM) said in a letter to the U.S. Department of Transportation, which was shared with Reuters, that it has obtained emails and other documents that suggest unsafe packaging and movement of implants removed from the brains of monkeys. These implants may have carried infectious diseases in violation of federal law, PCRM said.

The letter said records that the group obtained showed instances of pathogens, such as antibiotic-resistant staphylococcus and herpes B virus, that may have been transported without proper containment measures.

PCRM’s letter adds to the scrutiny facing Neuralink, which is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.

In December, Reuters reported that Neuralink has been under a federal investigation over potential animal welfare violations and that some of its staff made internal complaints about experiments being rushed, causing needless suffering and deaths.

The incidents that involved potential breaches of hazardous material transportation regulations happened in 2019, when Neuralink relied on University of California, Davis to help carry out its experiments on primates, according to the documents cited by PCRM.

While Neuralink’s partnership with UC Davis ended in 2020, PCRM said the company continues to employ the neurosurgeon who oversaw the experiments and other staff involved may also still be employed.

Reuters reviewed the UC Davis records cited by PCRM in its letter. It is unclear whether further records exist that provide a different or fuller account of what happened. PCRM obtained the records from UC Davis through public information requests. Neuralink messages and records not shared with UC Davis are not subject to such information requests.

Representatives for Neuralink, including Musk, and the Department of Transportation did not respond to comment requests. A UC Davis spokesperson would only say that the university abides by all biohazard and lab safety regulations.


PCRM’s letter said pathogens were carried on removed implants from monkeys after improper sanitization and packaging. The group said those pathogens could cause serious health issues in infected humans, such as bloodstream infections, pneumonia and severe brain damage, among other problems.

PCRM, which opposes the use of animals in medical research, did not identify any harm as a result of these incidents, but said Neuralink’s actions “may pose a serious and ongoing public health risk.”

“The company’s documented track record of sloppy, unsafe laboratory practices compel DOT to investigate and levy appropriate fines,” PCRM said in the letter.

PCRM said it also found instances that appear to describe UC Davis employees urging immediate biohazard training for Neuralink employees following incidents that had caused contamination concerns. On one occasion in April 2019, a UC Davis employee wrote in an email that the university’s primate center is “at risk” for “monkey contaminated hardware.”

“This is an exposure to anyone coming in contact with the contaminated explanted hardware and we are making a big deal about this because we are concerned for human safety,” wrote the employee, whose name was redacted from the records.

PCRM has raised concerns about Neuralink in the past. Last year, it wrote to federal officials about alleged animal-welfare issues during Neuralink’s research partnership with UC Davis, citing another set of records it obtained. A federal prosecutor in the Northern District of California referred PCRM’s complaint to the USDA Inspector General, which later launched the federal probe into Neuralink, Reuters previously reported.

During its partnership with UC Davis, Neuralink grew frustrated with what it regarded as the slow pace of testing on primates, current and former company employees told Reuters, and has since built out extensive in-house animal testing facilities. The company has missed deadlines set by Musk to proceed to human trials, however. His pressure on Neuralink’s staff to make progress contributed to mistakes plaguing some experiments, Reuters reported.

Tech

Microsoft to invest 2.2bn dollars in cloud and AI services in Malaysia

Microsoft to invest 2.2bn dollars in cloud and AI services in Malaysia

Published

on

By

Microsoft to invest 2.2bn dollars in cloud and AI services in Malaysia

Microsoft (MSFT.O) said on Thursday it will invest $2.2 billion over the next four years in Malaysia to expand cloud and artificial intelligence (AI) services in the company’s latest push to promote its generative AI technology in Asia.

The investment, the largest in Microsoft’s 32-year history in Malaysia, will include building cloud and AI infrastructure, creating AI-skilling opportunities for 200,000 people, and supporting the country’s developers, the company said.

“We want to make sure we have world class infrastructure right here in the country so that every organisation and start-up can benefit,” Microsoft Chief Executive Satya Nadella said during a visit to Kuala Lumpur.

Microsoft will also work with the Malaysian government to establish a national AI Centre of Excellence and enhance the nation’s cybersecurity capabilities, the company said in a statement.

Advertisement

Prime Minister Anwar Ibrahim, who met Nadella on Thursday, said the investment supported Malaysia’s efforts in developing its AI capabilities.

Microsoft is trying to expand its support for the development of AI globally. Nadella this week announced a $1.7 billion investment in neighbouring Indonesia and said Microsoft would open its first regional data centre in Thailand.

Continue Reading

Tech

Nvidia supplier SK Hynix says HBM chips almost sold out for 2025

Nvidia supplier SK Hynix says HBM chips almost sold out for 2025

Published

on

By

Nvidia supplier SK Hynix says HBM chips almost sold out for 2025

South Korea’s SK Hynix (000660.KS) said on Thursday that its high-bandwidth memory (HBM) chips used in AI chipsets were sold out for this year and almost sold out for 2025 as businesses aggressively expand artificial intelligence services.

“The HBM market is expected to continue to grow as data and (AI) model sizes increase,” Chief Executive Officer Kwak Noh-Jung told a news conference. “Annual demand growth is expected to be about 60% in the mid-to long-term.”

SK Hynix which competes with U.S. rival Micron (MU.O) and domestic behemoth Samsung Electronics (005930.KS) in HBM was until March the sole supplier of HBM chips to Nvidia, according to analysts who add that major AI chip purchasers are keen to diversify their suppliers to better maintain operating margins. Nvidia commands some 80% of the AI chip market.

Micron has also said its HBM chips were sold out for 2024 and that the majority of its 2025 supply was already allocated. It plans to provide samples for its 12-layer HBM3E chips to customers in March.

Advertisement

“As AI functions and performance are being upgraded faster than expected, customer demand for ultra-high-performance chips such as the 12-layer chips appear to be increasing faster than for 8-layer HBM3Es,” said Jeff Kim, head of research at KB Securities.

Samsung Electronics (005930.KS) which plans to produce its HBM3E 12-layer chips in the second quarter, said this week that this year’s shipments of HBM chips are expected to increase more than three-fold and it has completed supply discussions with customers. It did not elaborate further.

Last month, SK Hynix announced a $3.87 billion plan to build an advanced chip packaging plant in the U.S. state of Indiana with an HBM chip line and a 5.3 trillion won ($3.9 billion) investment in a new DRAM chip factory at home with a focus on HBMs.

Kwak said investment in HBM differed from past patterns in the memory chip industry in that capacity is being increased after making certain of demand first.

By 2028, the portion of chips made for AI, such as HBM and high-capacity DRAM modules, is expected to account for 61% of all memory volume in terms of value from about 5% in 2023, SK Hynix’s head of AI infrastructure Justin Kim said.

Last week, SK Hynix said in a post-earnings conference call that there may be a shortage of regular memory chips for smartphones, personal computers and network servers by the year’s end if demand for tech devices exceeds expectations.

Advertisement

The Nvidia (NVDA.O) supplier and the world’s second-largest memory chipmaker will begin sending samples of its latest HBM chip, called the 12-layer HBM3E, in May and begin mass producing them in the third quarter.

Continue Reading

Tech

Qualcomm jumps as AI sparks rebound in Chinese smartphone market

Qualcomm jumps as AI sparks rebound in Chinese smartphone market

Published

on

By

Qualcomm jumps as AI sparks rebound in Chinese smartphone market

Qualcomm (QCOM.O) shares rose 4% in premarket trading on Thursday after the smartphone-focused chipmaker signaled an AI-fueled rebound in demand, especially in China, after a two-year slump.

Sales to Chinese smartphone makers jumped 40% in the first half of its fiscal year, the company said on Wednesday, as buyers there gravitate toward higher-priced devices that can accommodate AI chatbots.

“Chinese vendors who traditionally relied more on MediaTek, are going to start leveraging Qualcomm’s high-end chips more as they push hard into the AI Agenda,” said IDC analyst Nabila Popal.

“They further represent an upside for Qualcomm because majority of the recovery is also going to be driven by Chinese OEMs this year, coming from a tough last two years.”

Advertisement

Qualcomm on Wednesday projected third-quarter sales that were above estimates as it also benefits from its IoT (Internet of things) and auto segments.

The company, the biggest supplier of smartphone chips, was on course to add more than $8 billion to its market value based on premarket movements. Other semiconductor firms such as Arm and Broadcom (AVGO.O) rose 2.8% and 2.4%, respectively.

According to preliminary data from research firm IDC, in the high-end segment, the AI buzz and the foldable products allowed the Android smartphone vendors to further differentiate themselves from Apple (AAPL.O) and garnered increased interest from Chinese consumers in the first quarter of 2024.

“We’re optimistic that numbers can be driven higher, given last year’s muted Android cycle and the likelihood of IoT(internet of things) improvement as inventory normalizes,” analysts at Wolfe Research said.

At least 14 analysts raised their price targets on Qualcomm, according to LSEG data.

Advertisement

Qualcomm’s shares have gained 13.5% this year following a 31.5% rise in 2023.

Shares of Apple, which is set to report earnings after market closes on Thursday, were up 1.05% in premarket trading.

Continue Reading

Trending

Copyright © GLOBAL TIMES PAKISTAN